$CABA
Cabaletta Bio, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Philadelphia, PA
CABA chart
What traders are saying about $CABA
Latest postsCabaletta Bio, Inc. news
- Cabaletta Bio, Inc. Estimates – NASDAQ:CABA
TradingView ·
- Cabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance ·
- Autoimmune CAR-T faces tough questions after Novartis, Bristol Myers study halts
biopharmadive.com ·
- Cabaletta Bio to Participate in Upcoming Investor Conferences
Yahoo Finance ·
- Cabaletta Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
Yahoo Finance ·
- Kyverna Therapeutics Sinks 13%: Here’s Why
247wallst.com ·
- How Cabaletta Bio (CABA) Is Turning Rese-cel Enrollment and New Financing Into a Clearer Autoimmune Cell Therapy Setup
Yahoo Finance ·
- Cathie Wood's ARK Invest Joins Cellares' $277 Million Series D
Yahoo Finance ·
- Cabaletta Bio Inc. (CABA) A Top Penny Stock Eyeing Rese-Cel Commercial Launch for Autoimmune Diseases
Yahoo Finance ·
- Cabaletta Bio Announces New Rese-cel Data and Development Updates Across Autoimmune Portfolio, Including Encouraging Early PC-Free Lupus Findings, at EULAR 2026 Congress
Yahoo Finance ·
- Pemphigus Vulgaris Market Analysis Report 2026-2036, Profiles of F. Hoffmann La Roche, Argenx, Sanofi, Syntimmune, Allmiral, Cabaletta Bio, and Novartis
Yahoo Finance ·
- Is Cabaletta Bio (CABA) Stock Outpacing Its Medical Peers This Year?
Yahoo Finance ·
Cabaletta Bio, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$167.9M | -$115.9M | -$67.7M | -$53.0M |
| Diluted EPS | $-2.10 | $-2.34 | $-1.65 | $-1.81 |
| Total assets (year end) | $165.1M | $185.0M | $253.7M | $117.0M |
| Cash and equivalents (year end) | $83.0M | $164.0M | $193.2M | $81.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Cabaletta Bio, Inc.
- Ticker
- CABA (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Philadelphia, PA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1759138
Frequently asked questions
What exchange is Cabaletta Bio, Inc. listed on?
Cabaletta Bio, Inc. trades on the Nasdaq under the ticker symbol CABA.
What industry is Cabaletta Bio, Inc. in?
Cabaletta Bio, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Cabaletta Bio, Inc. headquartered?
Cabaletta Bio, Inc.'s business address on file with the SEC is in Philadelphia, PA.
When does Cabaletta Bio, Inc.'s fiscal year end?
Cabaletta Bio, Inc.'s fiscal year ends on December 31.